EVEROLIMUS (Page 8 of 8)
Package/Label Display Panel – 2.5-mg-carton
PRINCIPAL DISPLAY PANEL
Package Label – 2.5 mg
Rx Only NDC 70377-010-22
Everolimus Tablets 2.5 mg
Each tablet contains 2.5 mg everolimus.
28 Tablets
Carton contains 4 individual blister cards of 7 tablets.
Package/Label Display Panel – 5-mg-carton
PRINCIPAL DISPLAY PANEL
Package Label – 5 mg
Rx Only NDC 70377-011-22
Everolimus Tablets 5 mg
Each tablet contains 5 mg everolimus.
28 Tablets
Carton contains 4 individual blister cards of 7 tablets.
Package/Label Display Panel – 7.5-mg-carton
PRINCIPAL DISPLAY PANEL
Package Label – 7.5 mg
Rx Only NDC 70377-012-22
Everolimus Tablets
Each tablet contains 7.5 mg everolimus.
28 Tablets
Carton contains 4 individual blister cards of 7 tablets.
Package/Label Display Panel – 10-mg-carton
PRINCIPAL DISPLAY PANEL
Package Label – 10 mg
Rx Only NDC 70377-013-22
Everolimus Tablets
Each tablet contains 10 mg everolimus.
28 Tablets
Carton contains 4 individual blister cards of 7 tablets.
Package/Label Display Panel – 2.5-mg-bottle
PRINCIPAL DISPLAY PANEL
Package Label –2.5 mg
NDC 70377-010-11
Everolimus Tablets
2.5 mg
Rx Only 30 Tablets
Package/Label Display Panel – 5-mg-bottle
PRINCIPAL DISPLAY PANEL
Package Label – 5 mg
NDC 70377-011-11
Everolimus Tablets
5 mg
Rx Only 30 Tablets
Package/Label Display Panel – 7.5-mg-bottle
PRINCIPAL DISPLAY PANEL
Package Label –7.5 mg
NDC 70377-012-11
Everolimus Tablets
7.5 mg
Rx Only 30 Tablets
Package/Label Display Panel – 10-mg-bottle
PRINCIPAL DISPLAY PANEL
Package Label – 10 mg
NDC 70377-013-11
Everolimus Tablets
10 mg
Rx Only 30 Tablets
EVEROLIMUS everolimus tablet | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
EVEROLIMUS everolimus tablet | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
EVEROLIMUS everolimus tablet | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
EVEROLIMUS everolimus tablet | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
Labeler — Biocon Pharma Inc. (080000063) |
Registrant — Biocon Pharma Limited (871412155) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Biocon Limited | 915076162 | api manufacture (70377-010), api manufacture (70377-011), api manufacture (70377-012), api manufacture (70377-013) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Biocon Pharma Limited | 871412155 | manufacture (70377-010), manufacture (70377-011), manufacture (70377-012), manufacture (70377-013) |
Revised: 06/2023 Biocon Pharma Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.